Genome-Wide Analysis of Aberrant Position and Sequence of Plasma DNA Fragment Ends in Patients With Cancer
Demographics (2)
- AGE - Subject age at enrollment (phv00528151.v1.p1)
- SEX - Biological sex (phv00528145.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for cancer (phv00528152.v1.p1)
Other (18)
- ANALYTE_TYPE - Analyte Type (phv00528154.v1.p1)
- BODY_SITE - Site of sample collection (phv00528158.v1.p1)
- COLLECTION_TUBE - Tube type for blood collection (phv00528161.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00528144.v1.p1)
- EXTRACTION_KIT - Kit used for plasma cell-free DNA extraction (phv00528162.v1.p1)
- IS_TUMOR - Tumor status (phv00528155.v1.p1)
- SAMPLE_ID - Sample ID (phv00528153.v1.p1)
- SAMPLE_ID - Sample ID (phv00528149.v1.p1)
- SEQUENCER - Model of Illumina sequencer used for whole genome sequencing (phv00528163.v1.p1)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00528147.v1.p1)
- SUBJECT_ID - Subject ID (phv00528143.v1.p1)
- SUBJECT_ID - Subject ID (phv00528150.v1.p1)
- SUBJECT_ID - Subject ID (phv00528148.v1.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00528146.v1.p1)
- TIMEPOINT - Order of this sample in longitudinal sample collection from the subject (phv00528159.v1.p1)
- TIMEPOINT_DAY - Days from the first sample collection to this sample collection (phv00528160.v1.p1)
- TUMOR_STAGE - Subject cancer stage at diagnosis (phv00528157.v1.p1)
- TUMOR_TYPE - Subject cancer type if applicable (phv00528156.v1.p1)